Latest Bioethics Stories
Art Caplan will discuss "End of Life: Legal, Medical and Ethical Issues" for the annual Batdorf Lecture at Alvernia University, March 18, 2014. Reading,
Hawaii Biotech Receives DoD Contract to Develop Anti-Botulism Drug HONOLULU, March 5, 2014 /PRNewswire/ -- The Department of Defense, Defense Threat Reduction Agency, has awarded Hawaii
6.8% improvement in FEV1 versus placebo in high FENO subset representing half of treated patients BOULDER, Colo., March 3, 2014 /PRNewswire/ -- Array BioPharma Inc.
- Study Meets Primary and Both Key Secondary Endpoints - BRISBANE, Calif., Feb. 25, 2014 /PRNewswire/ -- InterMune, Inc.
MELBOURNE, Australia and NEW YORK, Feb.
Results from Alpha BRAIN™ Pilot Study to Be Presented at the International Neuropsychological Society Annual Conference Austin, Texas (PRWEB) February 14,
All proceeds from this special photo shoot will benefit homeless dogs and cats. Washington, DC (PRWEB) February 13, 2014
The nonprofit organization, Animals for Armed Forces® Foundation, appreciates the support of Julian Omidi and Dr. Michael Omidi and their charity Animal Support.
Company continues to expand its board and leadership team as it moves toward completion of its Phase 3 gene therapy program and advancement of the industry's deepest pipeline of gene-based medicines PHILADELPHIA,
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- Withering but not falling off, as a blossom that persists on a twig after flowering.
More Images (1 images) »